Remove 2025 Remove Government Remove Provider Remove Telehealth
article thumbnail

MN Legislative Session 2025: MAFP Priorities Remain in Play

Minnesota Academy of Family Physicians

As our state legislature gets closer to special session, the Minnesota Academy of Family Physician’s (MAFP) lobbyist Megan Verdeja breaks down what’s happening at the Minnesota State Capitol and provides a recap of the 2025 session. Audio-Only Telehealth – Ensuring audio-only telehealth visits remain a reimbursable option.

article thumbnail

MN Legislative Session 2025: Updates on Hearings and Bills

Minnesota Academy of Family Physicians

SENATE HEALTH AND HUMAN SERVICES COMMITTEE Patient-Centered Care Program ( SF 1059 ): Proposal: The bill proposes removing managed care from MA by having the Department of Human Services (DHS) make direct payments to providers. The post MN Legislative Session 2025: Updates on Hearings and Bills appeared first on MAFP.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Green Practice News: April 2025

My Green Doctor

In This Issue : New Research: Teaching Patients about Climate Resilience Make the Pledge Today to Go Green Get Ready for Earth Day 2025 (part 2)! Behavior Change Happens in the Exam Room Unlike government agencies or corporations, healthcare professionals speak directly to individuals in a trusted, one-on-one setting. Let’s talk!

article thumbnail

Endocrinology, Diabetes and Metabolism Board Meeting Summary | Spring 2025

ABIM

Christine Twining, MD, Chair, ABIM Endocrinology, Diabetes and Metabolism Board The Endocrinology, Diabetes and Metabolism Board , which meets twice a year and is responsible for oversight of policy and assessment in the specialty, held its spring meeting on April 1, 2025. Community Practice in ABIM Governance* Erica N.

article thumbnail

Infectious Disease Board Meeting Summary | Spring 2025

ABIM

Erin Bonura, MD, Chair, ABIM Infectious Disease Board The Infectious Disease Board , which meets twice a year and is responsible for oversight of ABIM policy and assessment in the specialty, held its spring meeting on March 25, 2025. JD , whose terms on the Specialty Board end June 30, 2025.

article thumbnail

Senator Durbin Has Questions About FDA’s “Operational Capacity” to Oversee DTC Prescription Drug Advertising Amid Workforce Reductions – Don’t We All?

FDA Law Blog

Government Accountability Office (GAO) published a report finding that, for the years 2016-2018, the pharmaceutical industry spent on average for a sample of 553 drug products approximately $6 billion annually on DTC advertisements, with a significant portion of this spending allocated to television commercials. In 2021, the U.S.